Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Purchased by Avior Wealth Management LLC

Avior Wealth Management LLC increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1,570.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,554 shares of the company's stock after buying an additional 8,042 shares during the quarter. Avior Wealth Management LLC's holdings in Prestige Consumer Healthcare were worth $668,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in PBH. Envestnet Asset Management Inc. raised its holdings in shares of Prestige Consumer Healthcare by 14.9% in the second quarter. Envestnet Asset Management Inc. now owns 67,814 shares of the company's stock worth $4,669,000 after buying an additional 8,782 shares during the last quarter. Mercer Global Advisors Inc. ADV raised its stake in Prestige Consumer Healthcare by 6.7% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 5,969 shares of the company's stock worth $411,000 after acquiring an additional 374 shares during the last quarter. Canada Pension Plan Investment Board acquired a new stake in Prestige Consumer Healthcare during the 2nd quarter worth about $151,000. Thrivent Financial for Lutherans grew its stake in Prestige Consumer Healthcare by 37.3% during the 2nd quarter. Thrivent Financial for Lutherans now owns 59,152 shares of the company's stock valued at $4,073,000 after purchasing an additional 16,081 shares during the last quarter. Finally, Evergreen Capital Management LLC grew its stake in Prestige Consumer Healthcare by 5.4% during the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company's stock valued at $216,000 after purchasing an additional 160 shares during the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

PBH has been the subject of a number of research reports. Sidoti downgraded Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 target price for the company. in a report on Monday, December 9th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Friday. Raymond James upgraded shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research note on Thursday, December 19th. Finally, DA Davidson restated a "buy" rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $85.25.

Insider Buying and Selling

In related news, insider William P'pool sold 8,987 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total value of $735,585.95. Following the completion of the transaction, the insider now directly owns 20,058 shares of the company's stock, valued at approximately $1,641,747.30. This represents a 30.94 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Adel Mekhail sold 9,063 shares of Prestige Consumer Healthcare stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total transaction of $743,166.00. Following the sale, the executive vice president now directly owns 18,365 shares in the company, valued at approximately $1,505,930. This trade represents a 33.04 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,810 shares of company stock valued at $3,187,300. 1.60% of the stock is owned by corporate insiders.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE:PBH traded up $0.06 during trading on Friday, hitting $76.79. 217,886 shares of the stock traded hands, compared to its average volume of 226,830. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The company has a fifty day moving average price of $80.08 and a two-hundred day moving average price of $74.93. Prestige Consumer Healthcare Inc. has a 52-week low of $60.00 and a 52-week high of $86.36. The company has a market cap of $3.79 billion, a price-to-earnings ratio of 18.68, a P/E/G ratio of 2.17 and a beta of 0.51.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.09. The company had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. Prestige Consumer Healthcare's revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.07 earnings per share. As a group, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.46 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.